A rational approach to the diagnosis of polycystic ovarian syndrome during adolescence;Uma abordagem racional do diagnóstico da síndrome dos ovários policísticos na adolescência

Arquivos Brasileiros de Endocrinologia e Metabologia

Volumn 55, Issue 8, 2011, Pages 590-598

  Merino, Paulina M ^a   Codner, Ethel ^a   Cassorla, Fernando ^a  

^a UNIVERSITY OF CHILE   (Chile)

Author keywords

Adolescence; Anti m llerian hormone; Diagnosis; Hirsutism; Hyperandrogenism; Menstrual irregularities; Polycystic ovarian morphology; Polycystic ovarian syndrome; Puberty

Indexed keywords

ADOLESCENT; AGE; FEMALE; GYNECOLOGICAL EXAMINATION; HUMAN; HYPERANDROGENISM; NOMENCLATURE; OVARY POLYCYSTIC DISEASE; REVIEW; RISK FACTOR; STANDARD;

ADOLESCENT; AGE FACTORS; DIAGNOSTIC TECHNIQUES, OBSTETRICAL AND GYNECOLOGICAL; FEMALE; HUMANS; HYPERANDROGENISM; POLYCYSTIC OVARY SYNDROME; RISK FACTORS; TERMINOLOGY AS TOPIC;

EID: 84855417238     PISSN: 00042730     EISSN: 16779487     Source Type: Journal    
DOI: 10.1590/S0004-27302011000800013     Document Type: Review

References (71)

1. Knochenhauer ES, Key TJ, Kahsar-Miller M, Waggoner W, Boots LR, Azziz R. Prevalence of the polycystic ovary syndrome in unse-lected black and white women of the southeastern United States: a prospective study. J Clin Endocrinol Metab. 1998;83(9):3078-82.
2. Carmina E, Oberfeld SE, Lobo RA. The diagnosis of polycys-tic ovary syndrome in adolescents. Am J Obstet Gynecol. 2010;203(3):201.e1-5.
3. Shayya R, Chang RJ. Reproductive endocrinology of adolescent polycystic ovary syndrome. BJOG. 2010;117(2):150-5.
4. Stein I, Leventhal ML. Amenorrhea associated with bilateral polycystic ovaries. Am J Obstet Gynecol. 1935;29:181-91.
5. Zawadsky J, Dunaif A. Diagnostic criteria for polycystic ovary syndrome. In: Dunaif A, Givens JR, Haseltine F P, Merriam GR, ed. Polycystic ovary syndrome. Boston: Blackwell Scientific. 1992. p. 377-84.
6. The Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril. 2004;81(1):19-25.
7. Azziz R, Carmina E, Dewailly D, Diamanti-Kandarakis E, Escobar--Morreale H F, Futterweit W, et al. Criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an androgen excess society guideline. J Clin Endocrinol Metab. 2006;91(11):4237-45.
8. Merino P, Schulin-Zeuthen C, Codner E. [Current diagnosis of polycystic ovary syndrome: expanding the phenotype but generating new questions]. Rev Med Chil. 2009;137(8):1071-80.
9. Fraser IS, Critchley HO, Munro MG, Broder M. Can we achieve international agreement on terminologies and definitions used to describe abnormalities of menstrual bleeding? Hum Reprod. 2007;22(3):635-43.
10. Diaz A, Laufer MR, Breech LL. Menstruation in girls and adolescents: using the menstrual cycle as a vital sign. Pediatrics. 2006;118(5):2245-50.
11. Adams Hillard PJ. Menstruation in adolescents: what's normal, what's not. Ann N Y Acad Sci. 2008;1135:29-35.
12. Codner E, Eyzaguirre FC, Iniguez G, Lopez P, Perez-Bravo F, Torre-alba IM, et al. Ovulation rate in adolescents with type 1 diabetes mellitus. Fertil Steril. 2011;95(1):197-202.e1.
13. Rosenfeld RL. Clinical practice. Hirsutism. N Engl J Med. 2005;353(24):2578-88.
14. Martin KA, Chang RJ, Ehrmann DA, Ibanez L, Lobo RA, Rosenfeld RL, et al. Evaluation and treatment of hirsutism in premenopau-sal women: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2008;93(4):1105-20.
15. Ferriman D, Gallwey JD. Clinical assessment of body hair growth in women. J Clin Endocrinol Metab. 1961;21:1440-7.
16. Hatch R, Rosenfeld RL, Kim MH, Tredway D. Hirsutism: implications, etiology, and management. Am J Obstet Gynecol. 1981;140(7):815-30.
17. Welt CK, Arason G, Gudmundsson JA, Adams J, Palsdottir H, Gudlaugsdottir G, et al. Defining constant versus variable pheno-typic features of women with polycystic ovary syndrome using different ethnic groups and populations. J Clin Endocrinol Metab. 2006;91(11):4361-8.
18. Tellez R, Frenkel J. [Clinical evaluation of body hair in healthy women]. Rev Med Chil. 1995;123(11):1349-54.
19. Yildiz BO, Bolour S, Woods K, Moore A, Azziz R. Visually scoring hirsutism. Hum Reprod Update. 2010 Jun 30;16(1):51-64.
20. Hickey M, Doherty DA, Atkinson H, Sloboda DM, Franks S, Norman RJ, et al. Clinical, ultrasound and biochemical features of polycystic ovary syndrome in adolescents: implications for diagnosis. Hum Reprod. 2011;26(6):1469-77.
21. Gryngarten M, Bedecarras P, Ayuso S, Bergada C, Campo S, Escobar ME. Clinical assessment and serum hormonal profle in prepubertal hypertrichosis. Horm Res. 2000;54(1):20-5.
22. Azziz R, Carmina E, Dewailly D, Diamanti-Kandarakis E, Escobar--Morreale H F, Futterweit W, et al. The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report. Fertil Steril. 2009;91(2):456-88.
23. Slayden SM, Moran C, Sams WM, Boots LR, Azziz R. Hype-randrogenemia in patients presenting with acne. Fertil Steril. 2001;75(5):889-92.
24. Gonzalez ME, Cantatore-Francis J, Orlow SJ. Androgenetic alopecia in the paediatric population: a retrospective review of 57 patients. Br J Dermatol. 2010;163(2):378-85.
25. Azziz R, Sanchez LA, Knochenhauer ES, Moran C, Lazenby J, Stephens KC, et al. Androgen excess in women: experience with over 1000 consecutive patients. J Clin Endocrinol Metab. 2004;89(2):453-62.
26. Matsumoto AM, Bremner WJ. Serum testosterone assays--accu-racy matters. J Clin Endocrinol Metab. 2004;89(2):520-4.
27. Miller KK, Rosner W, Lee H, Hier J, Sesmilo G, Schoenfeld D, et al. Measurement of free testosterone in normal women and women with androgen defciency: comparison of methods. J Clin Endo-crinol Metab. 2004;89(2):525-33.
28. Hahn S, Kuehnel W, Tan S, Kramer K, Schmidt M, Roesler S, et al. Diagnostic value of calculated testosterone indices in the assessment of polycystic ovary syndrome. Clin Chem Lab Med. 2007;45(2):202-7.
29. Rosner W, Auchus RJ, Azziz R, Sluss PM, Raff H. Position statement: Utility, limitations, and pitfalls in measuring testosterone: an Endocrine Society position statement. J Clin Endocrinol Me-tab. 2007;92(2):405-13.
30. Willenberg HS, Bahlo M, Schott M, Wertenbruch T, Feldkamp J, Scherbaum WA. Helpful diagnostic markers of steroidogenesis for defning hyperandrogenemia in hirsute women. Steroids. 2008;73(1):41-6.
31. Mueller A, Cupisti S, Binder H, Hoffmann I, Kiesewetter F, Beck-mann MW, et al. Endocrinological markers for assessment of hype-randrogenemia in hirsute women. Horm Res. 2007;67(1):35-41.
32. Taieb J, Mathian B, Millot F, Patricot MC, Mathieu E, Queyrel N, et al. Testosterone measured by 10 immunoassays and by isotope-dilution gas chromatography-mass spectrometry in sera from 116 men, women, and children. Clin Chem. 2003;49(8):1381-95.
33. Davison SL, Bell R, Donath S, Montalto JG, Davis SR. Androgen levels in adult females: changes with age, menopause, and oo-phorectomy. J Clin Endocrinol Metab. 2005;90(7):3847-53.
34. Rieder J, Santoro N, Cohen HW, Marantz P, Coupey SM. Body shape and size and insulin resistance as early clinical predictors of hyperandrogenic anovulation in ethnic minority adolescent girls. J Adolesc Health. 2008;43(2):115-24.
35. Bronstein J, Tawdekar S, Liu Y, Pawelczak M, David R, Shah B. Age of onset of polycystic ovarian syndrome in girls may be earlier than previously thought. J Pediatr Adolesc Gynecol. 2011;24(1):15-20.
36. Azziz R, Carmina E, Dewailly D, Diamanti-Kandarakis E, Escobar--Morreale H F, Futterweit W, et al. Positions statement: criteria for defning polycystic ovary syndrome as a predominantly hype-randrogenic syndrome: an Androgen Excess Society guideline. J Clin Endocrinol Metab. 2006;91(11):4237-45.
37. Jonard S, Robert Y, Cortet-Rudelli C, Pigny P, Decanter C, Dewailly D. Ultrasound examination of polycystic ovaries: is it worth counting the follicles? Hum Reprod. 2003;18(3):598-603.
38. Jonard S, Robert Y, Dewailly D. Revisiting the ovarian volume as a diagnostic criterion for polycystic ovaries. Hum Reprod. 2005;20(10):2893-8.
39. Balen AH, Laven JS, Tan SL, Dewailly D. Ultrasound assessment of the polycystic ovary: international consensus defnitions. Hum Reprod Update. 2003;9(6):505-14.
40. Villarroel C, Merino PM, Lopez P, Eyzaguirre FC, Van Velzen A, Iniguez G, et al. Polycystic ovarian morphology in adolescents with regular menstrual cycles is associated with elevated anti--Mullerian hormone. Hum Reprod. 2011;26(10):2861-8.
41. Hart R, Doherty DA, Norman RJ, Franks S, Dickinson JE, Hickey M, et al. Serum antimullerian hormone (AMH) levels are elevated in adolescent girls with polycystic ovaries and the polycystic ovarian syndrome (PCOS). Fertility and sterility. 2010;94(3):1118-21.
42. Hickey M, Sloboda DM, Atkinson HC, Doherty DA, Franks S, Norman RJ, et al. The relationship between maternal and umbilical cord androgen levels and polycystic ovary syndrome in adolescence: a prospective cohort study. J Clin Endocrinol Metab. 2009;94(10):3714-20.
43. Codner E, Villarroel C, Eyzaguirre FC, Lopez P, Merino PM, Perez--Bravo F, et al. Polycystic ovarian morphology in postmenarchal adolescents. Fertil Steril. 2011;95(2):702-6.e1-2.
44. Hart R, Doherty DA, Norman RJ, Franks S, Dickinson JE, Hickey M, et al. Serum antimullerian hormone (AMH) levels are elevated in adolescent girls with polycystic ovaries and the polycystic ovarian syndrome (PCOS). Fertil Steril. 2010;94(3):1118-21.
45. Mortensen M, Rosenfeld RL, Littlejohn E. Functional signifcance of polycystic-size ovaries in healthy adolescents. J Clin Endocri-nol Metab. 2006;91(10):3786-90.
46. Murphy MK, Hall JE, Adams JM, Lee H, Welt CK. Polycystic ovarian morphology in normal women does not predict the development of polycystic ovary syndrome. J Clin Endocrinol Metab. 2006;91(10):3878-84.
47. Alsamarai S, Adams JM, Murphy MK, Post MD, Hayden DL, Hall JE, et al. Criteria for polycystic ovarian morphology in polycystic ovary syndrome as a function of age. J Clin Endocrinol Metab. 2009;94(12):4961-70.
48. Duijkers IJ, Klipping C. Polycystic ovaries, as defined by the 2003 Rotterdam consensus criteria, are found to be very common in young healthy women. Gynecol Endocrinol. 2010;26(3):152-60.
49. Polson DW, Adams J, Wadsworth J, Franks S. Polycystic ovaries---a common finding in normal women. Lancet. 1988;1(8590):870-2.
50. Farquhar CM, Birdsall M, Manning P, Mitchell JM, France J T. The prevalence of polycystic ovaries on ultrasound scanning in a population of randomly selected women. Aust N Z J Obstet Gynae-col. 1994;34(1):67-72.
51. Adams JM, Taylor AE, Crowley WF, Hall JE. Polycystic ovarian morphology with regular ovulatory cycles: insights into the pa-thophysiology of polycystic ovarian syndrome. J Clin Endocrinol Metab. 2004;89(9):4343-50.
52. Pigny P, Jonard S, Robert Y, Dewailly D. Serum anti-Mullerian hormone as a surrogate for antral follicle count for defnition of the polycystic ovary syndrome. J Clin Endocrinol Metab. 2006;91(3):941-5.
53. Visser JA, de Jong FH, Laven JS, Themmen A P. Anti-Mullerian hormone: a new marker for ovarian function. Reproduction. 2006;131(1):1-9.
54. Dewailly D, Pigny P, Soudan B, Catteau-Jonard S, Decanter C, Poncelet E, et al. Reconciling the defnitions of polycystic ovary syndrome: the ovarian follicle number and serum anti-Mullerian hormone concentrations aggregate with the markers of hyperan-drogenism. J Clin Endocrinol Metab. 2010;95(9):4399-405.
55. Franks S. Adult polycystic ovary syndrome begins in childhood. Best Pract Res Clin Endocrinol Metab. 2002;16(2):263-72.
56. Abbott DH, Barnett DK, Bruns CM, Dumesic DA. Androgen excess fetal programming of female reproduction: a developmental aetiology for polycystic ovary syndrome? Hum Reprod Update. 2005;11(4):357-74.
57. Recabarren SE, Padmanabhan V, Codner E, Lobos A, Duran C, Vi-dal M, et al. Postnatal developmental consequences of altered insulin sensitivity in female sheep treated prenatally with testosterone. Am J Physiol Endocrinol Metab. 2005;289(5):E801-6.
58. Sir-Petermann T, Maliqueo M, Angel B, Lara HE, Perez-Bravo F, Recabarren SE. Maternal serum androgens in pregnant women with polycystic ovarian syndrome: possible implications in prenatal androgenization. Hum Reprod. 2002;17(10):2573-9.
59. Crisosto N, Codner E, Maliqueo M, Echiburu B, Sanchez F, Cas-sorla F, et al. Anti-Mullerian hormone levels in peripubertal daughters of women with polycystic ovary syndrome. J Clin Endocri-nol Metab. 2007;92(7):2739-43.
60. Sir-Petermann T, Codner E, Perez V, Echiburu B, Maliqueo M, La-dron de Guevara A, et al. Metabolic and reproductive features before and during puberty in daughters of women with polycystic ovary syndrome. J Clin Endocrinol Metab. 2009;94(6):1923-30.
61. Hernandez MI, Mericq V. Chapter 21: Polycystic Ovarian Syndrome. Brook's Clinical Pediatric Endocrinology, 6th edition 2010; Edited by Brook C, Clayton P, Brown R. Blackwell Publishing; 2009. p. 559-70.
62. Jasik CB, Lustig RH. Adolescent obesity and puberty: the "perfect storm". Ann N Y Acad Sci. 2008;1135:265-79.
63. McCartney CR, Prendergast KA, Chhabra S, Eagleson CA, Yoo R, Chang RJ, et al. The association of obesity and hyperandrogene-mia during the pubertal transition in girls: obesity as a potential factor in the genesis of postpubertal hyperandrogenism. J Clin Endocrinol Metab. 2006;91(5):1714-22.
64. Dunkel L, Sorva R, Voutilainen R. Low levels of sex hormone---binding globulin in obese children. J Pediatr. 1985;107(1):95-7.
65. Santoro N, Torrens J, Crawford S, Allsworth JE, Finkelstein JS, Gold EB, et al. Correlates of circulating androgens in mid-life women: the study of women's health across the nation. J Clin Endo-crinol Metab. 2005;90(8):4836-45.
66. Sowers MR, Jannausch M, Randolph J F, McConnell D, Little R, Lasley B, et al. Androgens are associated with hemostatic and infammatory factors among women at the mid-life. J Clin Endo-crinol Metab. 2005;90(11):6064-71.
67. Coviello AD, Legro RS, Dunaif A. Adolescent girls with polycys-tic ovary syndrome have an increased risk of the metabolic syndrome associated with increasing androgen levels independent of obesity and insulin resistance. J Clin Endocrinol Metab. 2006;91(2):492-7.
68. Glueck CJ, Morrison JA, Friedman LA, Goldenberg N, Stroop DM, Wang P. Obesity, free testosterone, and cardiovascular risk factors in adolescents with polycystic ovary syndrome and regularly cycling adolescents. Metabolism. 2006;55(4):508-14.
69. Polak J F, Pencina MJ, Pencina KM, O'Donnell CJ, Wolf PA, D'Agostino RB Sr. Carotid-wall intima-media thickness and cardiovascular events. N Engl J Med. 2011;365(3):213-21.
70. Hurwitz Eller N, Netterstrom B. The intima media thickness and coronary risk factors. Int Angiol. 2001;20(2):118-25.
71. de Sousa G, Brodoswki C, Kleber M, Wunsch R, Reinehr T. Association between androgens, intima-media thickness and the metabolic syndrome in obese adolescent girls. Clin Endocrinol (Oxf). 2010;72(6):770-4.